NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Carcell Biopharma

Carcell Biopharma

Private
SingaporeHealthcare & Life Scienceshttps://carcell.com

Last Round

Seed

Nov 1, 2021

Company Overview

Carcell Biopharma is a healthcare company that develops biopharmaceutical platforms intended to promote next-generation cell and gene therapies, focusing on engineered red blood cells and non-viral gene delivery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

cell and gene therapyengineered red blood celleRBC platformlipid nanoparticle platformLNP platformnon-viral gene deliveryallogeneic cell therapyoff-the-shelf cell therapyCGTimmunomodulationdrug discovery platformautoimmune disease therapycancer immunotherapypre-clinical biotechrare disease therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Carcell Biopharma Comparables

Compare Carcell Biopharma with similar companies based on industry and business-model similarity.

Carcell Biopharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Carmine Therapeutics
86%
Scarlet Therapeutics
84%
Anokion
59%

Carcell Biopharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 1, 2021

Carcell Biopharma Investors

Notable investors and investment history

Carcell Biopharma investors
InvestorRounds
BioTrack CapitalSeed
EVX VenturesSeed
Hyfinity InvestmentsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2026

    Monthly visitors increased 68% MoM.

  • Jan 2, 2026

    Monthly visitors grew 31% MoM, reaching 783.

Carcell Biopharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Carcell Biopharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Carcell Biopharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range5
Year Founded2021
Last FundingNov 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.